Trial Profile
A multi-center randomized phase II study comparing corticosteroids alone versus corticosteroids and extracorporal photopheresis (ECP) as first-line treatment of standard risk Grade II acute graft-versus-host disease after allogeneic stem cell transplantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2023
Price :
$35
*
At a glance
- Drugs Methoxsalen (Primary) ; Steroids
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms ECP-aGVHD
- 18 Dec 2018 New trial record